Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 2, 2012, Pages 190-198

  Yang, Wei ^a   Yu, Xi Chong ^a   Chen, Xing Yan ^a   Zhang, Lu ^a   Lu, Cui Tao ^a   Zhao, Ying Zheng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

distribution; icariin; pharmacokinetics; propylene glycol liposomes

Indexed keywords

ICARIIN; LIPOSOME; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ENCAPSULATION; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY EXAMINATION; LIPOSOMAL DELIVERY; LUNG EXAMINATION; MAXIMUM PLASMA CONCENTRATION; MOLECULAR SIZE; MOUSE; NONHUMAN; PARTICLE SIZE; SPLEEN EXAMINATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUGS, CHINESE HERBAL; FLAVONOIDS; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; LIPOSOMES; MALE; MICE; PARTICLE SIZE; PHARMACEUTICAL VEHICLES; PROPYLENE GLYCOL; TISSUE DISTRIBUTION;

EID: 84855453300     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01388.x     Document Type: Article

References (33)

1. Shindel AW, et al,. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med 2010; 7: (4 Pt 1) 1518-1528.
2. Liu WJ, et al,. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian J Androl 2005; 7: 381-388.
3. Xu CQ, et al,. Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol 2010; 642: 146-153.
4. Zhu HR, et al,. Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke. Neuropharmacology 2010; 59: 70-76.
5. Zhang L, et al,. Inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin. Basic Clin Pharmacol Toxicol 2010; 107: 899-905.
6. Wang L, et al,. Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1. Eur J Pharmacol 2009; 609: 40-44.
7. Nie J, et al,. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus. Eur J Pharmacol 2010; 626: 213-218.
8. Urano T, Tohda C,. Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid beta-induced neurite atrophy. Phytother Res 2010; 24: 1658-1663.
9. Ye LK, et al,. Pharmacokinetics of icariin in rats. Chin Pharm J 1999; 34: 33-36.
10. Cai Y, et al,. Absorption and metabolism of icariin in the in situ single-pass perfused rat intestinal model. Chin Pharm J 2009; 44: 985-988.
11. Qiu F, et al,. Metabolism of orally administered icariin in rats. Acta Pharmaceutica Sinica 1999; 34: 222-226.
12. Chen Y, et al,. Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharm Res 2008; 25: 2190-2199.
13. Cheng S, et al,. HPLC analysis and pharmacokinetics of icariin in rats. J Sep Sci 2007; 30: 1307-1312. (Pubitemid 46979328)
14. Hashida M, et al,. Lipid carrier systems for targeted drug and gene delivery. Chem Pharm Bull (Tokyo) 2005; 53: 871-880. (Pubitemid 41327672)
15. Luo YK, et al,. Application of ultrasonic gas-filled liposomes in enhancing transfer for breast cancer-related antisense oligonucleotides: an experimental study. J Liposome Res 2008; 18: 341-351.
16. Zhao YZ, Lu CT,. Increasing the entrapment of protein-loaded liposomes with a modified freeze-thaw technique: a preliminary experimental study. Drug Dev Ind Pharm 2009; 35: 165-171.
17. Lee MJ, et al,. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. Pharm Res 1995; 12: 1055-1059.
18. ElBayoumi TA, Torchilin VP,. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. Clin Cancer Res 2009; 15: 1973-1980.
19. Yu RZ, et al,. Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-Ras encapsulated in stealth liposomes. Pharm Res 1999; 16: 1309-1315. (Pubitemid 29393623)
20. Elsayed MM, et al,. PG-liposomes: novel lipid vesicles for skin delivery of drugs. J Pharm Pharmacol 2007; 59: 1447-1450. (Pubitemid 47606462)
21. Lu CT, et al,. Comparing encapsulation efficiency and ultrasound-triggered release for protein between phospholipid-based microbubbles and liposomes. J Microencapsul 2010; 27: 115-121.
22. Zhao YZ, et al,. Experiment on the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles. J Drug Target 2010; 18: 430-437.
23. Jain S, et al,. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 2007; 8: E111.
24. Bendas ER, Tadros MI,. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech 2007; 8: E107.
25. Gabizon A, Papahadjopoulos D,. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 1988; 85: 6949-6953.
26. Barza M, et al,. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Invest Ophthalmol Vis Sci 1987; 28: 893-900. (Pubitemid 17070698)
27. Jin Y, et al,. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice. Acta Pharmacol Sin 2005; 26: 250-256. (Pubitemid 40203974)
28. Yamauchi M, et al,. Release of drugs from liposomes varies with particle size. Biol Pharm Bull 2007; 30: 963-966. (Pubitemid 46708649)
29. Takahashi D, et al,. Phagocytosis of liposome particles by rat splenic immature monocytes makes them transiently and highly immunosuppressive in ex vivo culture conditions. J Pharmacol Exp Ther 2011; 337: 42-49.
30. He W, et al,. Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung 1995; 45: 910-913.
31. Liang HR, et al,. Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense. Planta Med 1997; 63: 316-319.
32. Trammer B, et al,. Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo. Eur J Pharm Biopharm 2008; 70: 758-764.
33. Zhuang J, et al,. Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes. Int J Nanomedicine 2010; 5: 407-416.